Abstract
To address the need for cost-of-care conversations in prenatal care, the CONTINUE (cost conversations in routine prenatal care) study was conducted with prenatal patients to better understand the benefits of implementing a cost-of-care conversation “cost” tool into routine obstetrics (OB) care. This research team conducted a multi-phase, mixed-methods research study to identify 18 target benefits of a cost tool to initiate and standardize cost-of-care conversation and, subsequently, developed and validated a cost tool. The cost tool was piloted and data pertaining to cost tool benefits were collected through interviews and surveys. To comprehensively assess the cost tool’s utility, exploratory factor analysis was performed to classify the underlying factor structure of the 18 benefit item responses. Data includes patients’ self-reported experiences of benefit items, as collected from third trimester prenatal patient participants who received the tool at the beginning of their prenatal care in three midwestern-based hospital clinics within one healthcare system. The present study describes the factor analysis approach used to identify the three final factors that emerged from the data. This analysis provides a framework for exploring patient-specific predictors of experiencing the benefit-related factors of a cost tool incorporated into routine OB care.
Statements and Declarations This study was funded by the Robert Wood Johnson Foundation, #77290.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Robert Wood Johnson Foundation (Grant #77290)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study was granted expedited approval by Advocate Aurora Health (AAH) institutional review board, Downers Grove, IL on December 11, 2020. Approval number:20-264E.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
